| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) S Miyakis, MD Lockshin, T Atsumi, DW Branch, RL Brey, R Cervera, ... Journal of thrombosis and haemostasis 4 (2), 295-306, 2006 | 8807 | 2006 |
| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 578 | 2020 |
| Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2‐glycoprotein I N Di Simone, PL Meroni, N Del Papa, E Raschi, D Caliandro, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 430 | 2000 |
| Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases S Fukaya, S Yasuda, T Hashimoto, K Oku, H Kataoka, T Horita, T Atsumi, ... Rheumatology 47 (11), 1686-1691, 2008 | 417 | 2008 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 415 | 2023 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 404 | 2018 |
| Association of autoantibodies against the phosphatidylserine–prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant T Atsumi, M Ieko, ML Bertolaccini, K Ichikawa, A Tsutsumi, E Matsuura, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 381 | 2000 |
| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 350 | 1998 |
| Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events K Otomo, T Atsumi, O Amengual, Y Fujieda, M Kato, K Oku, T Horita, ... Arthritis & Rheumatism 64 (2), 504-512, 2012 | 317 | 2012 |
| Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195 K Tsuchida, Z Makita, S Yamagishi, T Atsumi, H Miyoshi, S Obara, ... Diabetologia 42, 579-588, 1999 | 302 | 1999 |
| 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends ML Bertolaccini, O Amengual, L Andreoli, T Atsumi, CB Chighizola, ... Autoimmunity reviews 13 (9), 917-930, 2014 | 284 | 2014 |
| Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA–associated microscopic polyangiitis D Nakazawa, H Shida, U Tomaru, M Yoshida, S Nishio, T Atsumi, A Ishizu Journal of the American Society of Nephrology 25 (5), 990-997, 2014 | 282 | 2014 |
| Complement activation in patients with primary antiphospholipid syndrome K Oku, T Atsumi, M Bohgaki, O Amengual, H Kataoka, T Horita, S Yasuda, ... Annals of the rheumatic diseases 68 (6), 1030-1035, 2009 | 276 | 2009 |
| Circulating oxidized LDL forms complexes with β2-glycoprotein I: implication as an atherogenic autoantigen K Kobayashi, M Kishi, T Atsumi, ML Bertolaccini, H Makino, N Sakairi, ... Journal of lipid research 44 (4), 716-726, 2003 | 275 | 2003 |
| Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial A Deodhar, D van der Heijde, LS Gensler, TH Kim, WP Maksymowych, ... The Lancet 395 (10217), 53-64, 2020 | 250 | 2020 |
| Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients NM Shah, MA Khamashta, T Atsumi, GRV Hughes Lupus 7 (1), 3-6, 1998 | 250 | 1998 |
| Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, T Koike, GRV Hughes Rheumatology 35 (12), 1239-1243, 1996 | 224 | 1996 |
| The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery KY Cho, H Miyoshi, S Kuroda, H Yasuda, K Kamiyama, J Nakagawara, ... Journal of stroke and cerebrovascular diseases 22 (7), 910-918, 2013 | 217 | 2013 |
| A specific ligand for β2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages K Kobayashi, E Matsuura, Q Liu, J Furukawa, K Kaihara, J Inagaki, ... Journal of lipid research 42 (5), 697-709, 2001 | 198 | 2001 |
| ‘Non-criteria’aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010 ML Bertolaccini, O Amengual, T Atsumi, WL Binder, B Laat, R Forastiero, ... Lupus 20 (2), 191-205, 2011 | 192 | 2011 |
